Researchers are investigating how infant antibiotic use affects the airway and gut microbiome, which could inform interventions to reduce childhood asthma risk in children needing antibiotics in early life.
Researchers are investigating how infant antibiotic use affects the airway and gut microbiome, which could inform interventions to reduce childhood asthma risk in children needing antibiotics in early life.
Read More
Taking antibiotics when sick with the flu might actually backfire, making it more likely for patients to develop serious bacterial pneumonia instead of preventing it, Cedars-Sinai researchers found.
Read More
Pneumonia is a potentially life-threatening infection of the lungs that inflames alveoli and spurs the overproduction of purulent material. Typically afflicting neonates and seniors, the COVID pandemic has revealed the importance of proper pneumonia care for all patients.Â
Read More
Children with pneumonia who were visited by medical clowns had shorter hospital stays and required fewer days of intravenous antibiotics.
Read More
A new model shows that combining antibiotics with enzymes improved the removal of tough biofilms in VAP, a finding that could lead to more effective treatments.
Read More
The study aims to determine whether delayed antibiotics, compared to immediate prescribing, results in decreased antibiotic use and similar clinical improvement in children with mild pneumonia.
Read More
Many children with recurrent wheezing have undetected lung infections that may be more effectively treated with antivirals instead of commonly prescribed steroids.
Read More
The study results confirm omadacycline as a safe and effective treatment for moderate to severe community-acquired bacterial pneumonia, demonstrating non-inferiority to moxifloxacin.
Read More
Giving a gut bacteria-derived molecule as a dietary supplement to children might protect them against adult-onset asthma, research suggests.Â
Read More
Antibiotics in tuberculosis patients can be accurately monitored through a fingerprint sweat test, offering a less invasive alternative to blood tests, research finds.
Read More
A five-year trend study shows a rebound in inappropriate use of antibiotics after an early pandemic dip.
Read More
Hospitals still treated over 40% of patients battling highly resistant infections exclusively with the older, generic agents, an NIH study finds.
Read More
Antibiotics provided no measurable impact on the severity or duration of coughs, even if a bacterial infection was present, in patients seeking care for lower respiratory tract infections.
Read More
Researchers are developing liquid nanoparticles to bypass the barriers posed by thick mucus and frequent infections in cystic fibrosis lungs and prevent antimicrobial resistance.
Read More
The injection received FDA approval for adults and pediatric patients aged 3 months and older.Â
Read More
Researchers in the United Kingdom have isolated a jumbo phage from wastewater with the potential to fight lung infections caused by Burkholderia cenocepacia.
Read More
Researchers have invented a new artificial intelligence model that can design billions of new antibiotic molecules that are inexpensive and easy to build in the laboratory.Â
Read More
The machine learning technique can help detect whether antibiotic use is critical for patients with these infections.
Read More
Administering azithromycin to pregnant women who deliver vaginally is a cost-saving treatment for reducing maternal sepsis, death or infection in developing countries.
Read More
Surprisingly, one bacterial species tended to dominate in certain patients with IPF who were not treated with antibiotics—and those patients were more likely to survive.
Read More
A statewide pay-for-performance intervention cut rates of inappropriate antibiotic prescriptions to treat acute respiratory tract infections by an average of 18 percentage points across two large Los Angeles hospitals.
Read More
Scientists have used artificial intelligence to discover a new antibiotic that could be used to fight a deadly, drug-resistant pathogen that strikes vulnerable hospital patients.
Read More
The discovery of nourseothricin in the 1940s generated high hopes for it as a powerful agent against Gram-negative bacteria, but its development was dropped after proving toxic to kidneys. However, researchers are now taking another look.
Read More
New research to be presented at the European Congress of Clinical Microbiology & Infectious Diseases suggests restrictive antibiotic strategy for viral respiratory infections like influenza may be warranted.
Read More
